Literature DB >> 9296414

Intracranial pressure, middle cerebral artery flow velocity, and plasma inorganic fluoride concentrations in neurosurgical patients receiving sevoflurane or isoflurane.

A A Artru1, A M Lam, J O Johnson, R J Sperry.   

Abstract

UNLABELLED: This study examined the concentration-related effects of sevoflurane and isoflurane on cerebral physiology and plasma inorganic fluoride concentrations. Middle cerebral artery flow velocity (Vmca), intracranial pressure (ICP), electroencephalogram (EEG) activity, and jugular bulb venous oxygen saturation were measured, and cerebral perfusion pressure (CPP) and estimated cerebral vascular resistance (CVRe) were calculated at baseline and at 0.5, 1.0, and 1.5 minimum alveolar anesthetic concentration (MAC) sevoflurane (n = 8) or isoflurane (n = 6). Mannitol 0.5-0.75 g/kg was given before dural incision, and blood was sampled for plasma inorganic fluoride during surgery and for up to 72 h postoperatively. Both sevoflurane and isoflurane decreased Vmca (to 31 +/- 12 - 36 +/- 14 cm/s, mean +/- SD), did not significantly alter ICP (13 +/- 9 - 15 +/- 11 mm Hg), and did not cause epileptiform EEG activity. With sevoflurane, decreased Vmca was accompanied by decreased CPP and unchanged CVRe at 0.5 MAC, and unchanged CPP and increased CVRe at 1.0 and 1.5 MAC. Plasma inorganic fluoride was 39.0 +/- 12.9 microM at the end of anesthesia (3.2 +/- 2.0 MAC hours) with sevoflurane, similar to the value (36.2 +/- 3.9 microM) for 3.7 +/- 0.1 MAC hours sevoflurane in patients not receiving mannitol. Decreased Vmca during sevoflurane presumably results from decreased cerebral metabolic rate, with CVRe changing secondarily in accord with CPP. Plasma inorganic fluoride does not seem to be altered by mannitol-induced diuresis. IMPLICATIONS: In neurosurgical patients, sevoflurane decreased middle cerebral artery flow velocity and caused no epileptiform electroencephalogram activity and no increase of intracranial pressure or plasma inorganic fluoride. These effects are suitable for neurosurgery. Two other possible effects of sevoflurane, i.e., increased cerebrospinal fluid volume and/or intracranial elastance, may not be suitable for neurosurgery and warrant further study.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9296414     DOI: 10.1097/00000539-199709000-00019

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  11 in total

Review 1.  Sevoflurane in paediatric anaesthesia: a review.

Authors:  K L Goa; S Noble; C M Spencer
Journal:  Paediatr Drugs       Date:  1999 Apr-Jun       Impact factor: 3.022

2.  You can't manage what you don't measure.

Authors:  Annelies Moerman; Anthony R Absalom
Journal:  J Clin Monit Comput       Date:  2015-10-14       Impact factor: 2.502

3.  Volatile isoflurane sedation in cerebrovascular intensive care patients using AnaConDa(®): effects on cerebral oxygenation, circulation, and pressure.

Authors:  Julian Bösel; Jan C Purrucker; Frank Nowak; Julian Renzland; Petra Schiller; Eva Benveniste Pérez; Sven Poli; Benjamin Brunn; Werner Hacke; Thorsten Steiner
Journal:  Intensive Care Med       Date:  2012-10-25       Impact factor: 17.440

Review 4.  Pathophysiological and clinical considerations in the perioperative care of patients with a previous ischaemic stroke: a multidisciplinary narrative review.

Authors:  Jatinder S Minhas; William Rook; Ronney B Panerai; Ryan L Hoiland; Phil N Ainslie; Jonathan P Thompson; Amit K Mistri; Thompson G Robinson
Journal:  Br J Anaesth       Date:  2019-12-06       Impact factor: 9.166

Review 5.  Sevoflurance: approaching the ideal inhalational anesthetic. a pharmacologic, pharmacoeconomic, and clinical review.

Authors:  L Delgado-Herrera; R D Ostroff; S A Rogers
Journal:  CNS Drug Rev       Date:  2001

6.  Auditory evoked potential index does not correlate with observer assessment of alertness and sedation score during 0.5% bupivacaine spinal anesthesia with nitrous oxide sedation alone.

Authors:  Junko Ichikawa; Kumiko Taira; Keiko Nishiyama; Masato Endo; Mitsuharu Kodaka; Miwako Kawamata; Makiko Komori; Makoto Ozaki
Journal:  J Anesth       Date:  2012-01-12       Impact factor: 2.078

7.  Mild trigonocephaly and intracranial pressure: report of 56 patients.

Authors:  Takeyoshi Shimoji; Naoki Tomiyama
Journal:  Childs Nerv Syst       Date:  2004-06-05       Impact factor: 1.475

8.  Long-term isoflurane therapy for refractory bronchospasm associated with herpes simplex pneumonia in a heart transplant patient.

Authors:  C Hornuss; M Firsching; M Dolch; A Martignoni; A Peraud; J Briegel
Journal:  Case Rep Med       Date:  2010-12-16

Review 9.  Sevoflurane.

Authors:  Stefan De Hert; Anneliese Moerman
Journal:  F1000Res       Date:  2015-08-25

10.  Long-term monitoring of intracranial pressure in freely-moving rats; impact of different physiological states.

Authors:  Sajedeh Eftekhari; Connar Stanley James Westgate; Katrine Printz Johansen; Signe Rath Bruun; Rigmor H Jensen
Journal:  Fluids Barriers CNS       Date:  2020-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.